Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed ...

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Intera ...

Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Intera Oncology, a privately held medical device ...

Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate at the Piper ...

Adcendo, a biotech company focused on the development of first-in-class ADCs for the treatment of cancers with a high unmet medical need, today announced the successful closing of an oversubscribed ...

Bill McClellan writes: If Congress were to declare Jan. 6 a national holiday, what would that matter to you and me? A day off ...

Based on the TNM classification [21]. HA: Hepatic artery; PV: Portal vein. • T1: Tumor confined to the bile duct, with extension up to the muscle layer or fibrous tissue • T2a: Tumor invades ...

Christopher Burge was on 'Jeopardy!' on Nov. 19 and shared he has Stage 4 colon cancer at 34. He spoke with TODAY.com about ...

The biopsy confirmed that Packard had “adenocarcinoma, which is the most common form of colon cancer,” and a CT scan discovered that the cancer had spread to his liver, making his diagnosis Stage 4 or ...

This is supported by both its intellectual property and the Symplicity Spyral catheter design, which enables access and treatment of the common hepatic artery – a vascular target rich with sympa ...

Also in the press release, Medtronic stated that it intends to investigate multiorgan—hepatic artery and renal artery—denervation with the Symplicity Spyral catheter in the planned SPYRAL GEMINI ...